ICU Medical (ICU Medical) GF Value : $216.78 (As of Apr. 27, 2024)

View and export this data going back to 1992. Start your Free Trial

What is ICU Medical GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-27), ICU Medical's share price is $94.84. ICU Medical's GF Value is $216.78. Therefore, ICU Medical's Price-to-GF-Value for today is 0.44.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes ICU Medical is Possible Value Trap, Think Twice.

ICU Medical (NAS:ICUI) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

ICU Medical's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	94.84	/	216.78
	=	0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICU Medical GF Value Related Terms

Thank you for viewing the detailed overview of ICU Medical's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ICU Medical (ICU Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICU Medical Inc (NAS:ICUI) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

951 Calle Amanecer, San Clemente, CA, USA, 92673

Website

https://www.icumed.com

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.

Executives

Daniel Woolson	officer: VP, GM-Infusion Capital	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Christian B. Voigtlander	officer: Chief Operating Officer	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Vivek Jain	director, officer: Chairman and CEO	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Elisha W Finney	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Virginia Ruth Sanzone	officer: VP, General Counsel	951 CALLE AMANECER, SAN CLEMENTE CA 92673
George A Lopez	director, officer: Chairman, other: Chairman	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
William Seeger	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Smiths Group International Holdings Ltd	10 percent owner	C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB
Group Plc Smiths	10 percent owner	765 FINCHKEY ROAD, LONDON X0 00000
Kolleen T Kennedy	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Robert S Swinney	director	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Laurie Hernandez	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Brian Michael Bonnell	officer: Chief Financial Officer	ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Scott E Lamb	officer: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Kevin J Mcgrody	other: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673